China Pharma Holdings (CHPI) Inventory Turnover Ratio, from second quarter 2012 to second quarter 2011, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
China Pharma Holdings, Inc.  (CHPI)
 

China Pharma Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

China Pharma Holdings's inventory turnover ratio, the ratio that measures China Pharma Holdings's ability to manage its supply chain, sequentially decreased to 29.7 in the second quarter 2012, which does not come as a surprise, as the China Pharma Holdings continue to experience headwinds, which also impact its supply chain. China Pharma Holdings's average inventory processing period in the Jun 30 2012 quarter, has increased to 12 days, from 10 days, in the Mar 31 2012 quarter.

Within Healthcare sector 9 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2012 compared to previous quarter at no. .

CHPI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is China Pharma Holdings, Inc. Market Share?

What is Inventory Turnover Ratio?




CHPI Inventory Turnover Ratio (Jun 30 2012)
II. Quarter
(Mar 31 2012)
I. Quarter
(Dec 31 2011)
IV. Quarter
(Sep 30 2011)
III. Quarter
(Jun 30 2011)
II. Quarter
Y / Y Inventory Growth 75.89 % 82.62 % - - -
Y / Y Cost of Sales Growth -31.99 % -0.99 % -21.14 % 27.79 % -
Inventory Turnover Ratio (TTM) 29.7 37.71 45.11 71.06 100.15
CHPI's Total Ranking # # # # #
Average inventory processing period 12 10 8 5 4
Seq. Inventory Growth -10.49 % 30.1 % 49.77 % 0.85 % -7.07 %
Seq. Cost of Sales Growth 4.38 % -1.93 % -14.07 % -22.69 % 51.96 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 10
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
29.7 29.7 29.7
(Jun 30 2012)  




Financial Statements
China Pharma Holdings's Inventories $ 0 Millions Visit CHPI's Balance sheet
China Pharma Holdings's Cost of Revenues TTM $ 6 Millions Visit CHPI's Income Statement
What are CHPI's Sales? Visit CHPI's Sales by Segment

Other Inventory Turnover Ratios
China Pharma Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CHPI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CHPI's Competitors
Inventory Turnover Ratio for CHPI's Suppliers
Inventory Turnover Ratio for CHPI's Customers

You may also want to know
CHPI's Sales Growth Rates CHPI's Pe Price to earnings ratio CHPI's Receivables Turnover Ratio CHPI's Stock Quote
CHPI's Net Income Growth Rates CHPI's Ps Price to Sales ratio CHPI's Sales per Employee CHPI's Asset Turnover Ratio
CHPI's Net Margin CHPI's Pb Price to Book ratio CHPI's Financial Strength Ratios CHPI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2012, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2012 Inventories at quarter ending Jun 30 2012
Davita Inc   68.12 $ 4,978.956  Millions$ 73  Millions
Quest Diagnostics Inc  50.18 $ 4,420.926  Millions$ 88  Millions
Labcorp Holdings Inc   30.70 $ 3,343.600  Millions$ 109  Millions
China Pharma Holdings, Inc.  29.70 $ 5.634  Millions$ 0  Millions
Healthcare Services Group Inc   25.74 $ 645.743  Millions$ 25  Millions
Veru Inc   18.73 $ 11.886  Millions$ 1  Millions
Rockwell Medical inc   16.85 $ 41.761  Millions$ 2  Millions
Cryoport inc   15.02 $ 0.699  Millions$ 0  Millions
Insulet Corporation  11.96 $ 167.738  Millions$ 14  Millions
Inotiv Inc   11.25 $ 19.966  Millions$ 2  Millions
Aim Immunotech Inc   11.10 $ 15.037  Millions$ 1  Millions
Igc Pharma Inc   10.87 $ 2.866  Millions$ 0  Millions
Mit Holding, Inc.  10.31 $ 1.570  Millions$ 0  Millions
Dyne Therapeutics Inc   10.21 $ 592.000  Millions$ 58  Millions
Tenet Healthcare Corp  9.91 $ 1,574.000  Millions$ 159  Millions
Wearable Health Solutions, Inc.  9.89 $ 0.424  Millions$ 0  Millions
Protalix Biotherapeutics inc   9.65 $ 4.819  Millions$ 0  Millions
Align Technology inc   9.15 $ 104.669  Millions$ 11  Millions
Option Care Health Inc   8.79 $ 285.165  Millions$ 32  Millions
China Yct International Group, Inc.  8.06 $ 18.197  Millions$ 2  Millions
Antares Pharma Inc   7.40 $ 6.329  Millions$ 1  Millions
Patterson Companies Inc   7.29 $ 2,407.526  Millions$ 330  Millions
Ufp Technologies Inc   7.12 $ 69.011  Millions$ 10  Millions
Bohai Pharmaceuticals Group, Inc.  7.00 $ 23.741  Millions$ 3  Millions
Adynxx, Inc.  6.85 $ 1.378  Millions$ 0  Millions
Integrated Biopharma Inc  6.83 $ 31.347  Millions$ 5  Millions
Agenus Inc  6.77 $ 0.152  Millions$ 0  Millions
Hill rom Holdings Inc   6.46 $ 649.100  Millions$ 101  Millions
Oncternal Therapeutics Inc   5.91 $ 0.830  Millions$ 0  Millions
China Pediatric Pharmaceuticals, Inc.  5.40 $ 4.461  Millions$ 1  Millions

Date modified: 2026-09-02T20:25:00+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.